Breast cancer
Results
Other
This study looked at blood samples from people with breast cancer to see why they had different side effects and results from the same chemotherapy.
It included women who had taken part in one of the following breast cancer trials:
NEAT
McNEAT
tAnGO or Neo-tAnGo
Or, had or epirubicin with CMF chemotherapy.
Recruitment start: 31 May 2005
Recruitment end: 30 June 2010
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Jean Abraham
Cambridge University Hospitals NHS Foundation Trust
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
University of Cambridge
Last reviewed: 19 June 2017
CRUK internal database number: 1350